PL3377634T3 - Dostarczanie białek z wykorzystaniem bakterii - Google Patents

Dostarczanie białek z wykorzystaniem bakterii

Info

Publication number
PL3377634T3
PL3377634T3 PL16825704T PL16825704T PL3377634T3 PL 3377634 T3 PL3377634 T3 PL 3377634T3 PL 16825704 T PL16825704 T PL 16825704T PL 16825704 T PL16825704 T PL 16825704T PL 3377634 T3 PL3377634 T3 PL 3377634T3
Authority
PL
Poland
Prior art keywords
bacteria
based protein
protein delivery
delivery
protein
Prior art date
Application number
PL16825704T
Other languages
English (en)
Inventor
Simon ITTIG
Marlise AMSTUTZ
Christoph Kasper
Original Assignee
Universität Basel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universität Basel filed Critical Universität Basel
Publication of PL3377634T3 publication Critical patent/PL3377634T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL16825704T 2015-11-19 2016-11-17 Dostarczanie białek z wykorzystaniem bakterii PL3377634T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15195493 2015-11-19
EP16825704.6A EP3377634B1 (en) 2015-11-19 2016-11-17 Bacteria-based protein delivery
PCT/EP2016/078087 WO2017085235A1 (en) 2015-11-19 2016-11-17 Bacteria-based protein delivery

Publications (1)

Publication Number Publication Date
PL3377634T3 true PL3377634T3 (pl) 2021-03-08

Family

ID=54697465

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16825704T PL3377634T3 (pl) 2015-11-19 2016-11-17 Dostarczanie białek z wykorzystaniem bakterii

Country Status (22)

Country Link
US (1) US11702663B2 (pl)
EP (1) EP3377634B1 (pl)
JP (1) JP6937752B2 (pl)
KR (1) KR102689434B1 (pl)
CN (1) CN108884466B (pl)
AU (1) AU2016355975B2 (pl)
CY (1) CY1123654T1 (pl)
DK (1) DK3377634T3 (pl)
EA (1) EA039922B1 (pl)
ES (1) ES2830251T3 (pl)
HR (1) HRP20201792T1 (pl)
HU (1) HUE051184T2 (pl)
IL (1) IL259050B2 (pl)
LT (1) LT3377634T (pl)
PL (1) PL3377634T3 (pl)
PT (1) PT3377634T (pl)
RS (1) RS61046B1 (pl)
SG (1) SG11201803642WA (pl)
SI (1) SI3377634T1 (pl)
SM (1) SMT202000620T1 (pl)
WO (1) WO2017085235A1 (pl)
ZA (1) ZA201803901B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014071182A1 (en) 2012-11-01 2014-05-08 Massachusetts Institute Of Technology Directed evolution of synthetic gene cluster
EP3145946B1 (en) 2014-05-21 2019-08-14 Universität Basel Bacteria-based protein delivery
KR102197507B1 (ko) 2015-07-13 2020-12-31 피벗 바이오, 인크. 식물 형질 개선을 위한 방법 및 조성물
AU2016358257B2 (en) 2015-11-19 2023-08-17 Universitat Basel Virulence attenuated bacteria for treatment of malignant solid tumors
PT3559022T (pt) 2016-12-20 2021-08-19 Univ Basel Distribuição de proteínas baseada em bactérias com virulência atenuada
JP7420712B2 (ja) 2017-10-25 2024-01-23 ピボット バイオ, インコーポレイテッド 窒素を固定する操作された微生物を改良するための方法および組成物
EP3813511A4 (en) 2018-06-27 2022-08-03 Pivot Bio, Inc. GUIDED MICROBIAL REMODELING, PLATFORM FOR RATIONAL IMPROVEMENT OF MICROBIAL SPECIES FOR AGRICULTURE
WO2020190363A1 (en) 2019-03-19 2020-09-24 Massachusetts Institute Of Technology Control of nitrogen fixation in rhizobia that associate with cereals
CN114008221A (zh) 2019-04-25 2022-02-01 皮沃特生物股份有限公司 用于分离和表征由化学诱变产生的泌铵突变体库的高通量方法
WO2022087856A1 (zh) * 2020-10-26 2022-05-05 南京吉芮康生物科技研究院有限公司 一种减毒沙门氏菌分泌表达rbd结构域蛋白的新型冠状病毒疫苗抗原递呈系统及其应用
KR20230098197A (ko) * 2020-10-27 2023-07-03 티3 파마슈티컬스 아게 세균 기반한 단백질 전달
EP4314036A1 (en) * 2021-03-25 2024-02-07 T3 Pharmaceuticals AG Pharmaceutical combinations for treating cancer
PH12023552423A1 (en) * 2021-03-25 2024-02-19 T3 Pharmaceuticals Ag Pharmaceutical combinations for treating cancer
KR102873285B1 (ko) * 2022-01-03 2025-10-20 고려대학교 세종산학협력단 스캐폴드 기반의 다중항원을 포함하는 코로나바이러스 감염병 예방 또는 치료용 항원 조성물
CN117362451B (zh) * 2023-12-04 2024-03-08 北京质肽生物医药科技有限公司 一种包含tev蛋白酶的融合蛋白、制备方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965381A (en) * 1998-03-06 1999-10-12 Ludwig Institute For Cancer Research Delivery of proteins into eukaryotic cells with recombinant yersinia
WO2000002996A2 (en) * 1998-07-10 2000-01-20 Cornell Research Foundation, Inc. Recombinant constructs and systems for secretion of proteins via type iii secretion systems
WO2002026819A2 (en) 2000-09-26 2002-04-04 Roger Williams Hospital Recombinant bcg vaccines for the prevention and treatment of cancer
US20040147719A1 (en) * 2001-03-26 2004-07-29 Guy Cornelis Type III bacterial strains for use in medicine
FR2862312B1 (fr) * 2003-11-13 2006-02-17 Univ Grenoble 1 Outil de transfert et de production de proteines mettant en oeuvre le systeme de secretion de type iii de pseudomonas
EP1661912A1 (en) * 2004-11-29 2006-05-31 Xigen S.A. Fusion protein comprising a BH3-domain of a BH3-only protein
WO2007044406A2 (en) 2005-10-04 2007-04-19 Ludwig Institute For Cancer Research Methods for stimulating an immune response using bacterial antigen delivery system
WO2008019183A2 (en) * 2006-05-18 2008-02-14 The Regents Of The University Of California Biopolymer and protein production using type iii secretion systems of gram negative bacteria
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
JP5670875B2 (ja) 2008-03-17 2015-02-18 ウニベルジテーツクリニクム ミュンスター カーゴ分子の送達ビヒクルおよび炎症反応を免疫調節するための生物学的治療剤としてのYopM
US8524220B1 (en) * 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
CN105764926A (zh) * 2013-09-24 2016-07-13 梅迪塞纳医疗股份有限公司 白介素-4受体结合融合蛋白及其应用
US10143743B2 (en) * 2013-11-18 2018-12-04 Yale University Non-replicating bacterial nanoparticle delivery system and methods of use
EP3145946B1 (en) * 2014-05-21 2019-08-14 Universität Basel Bacteria-based protein delivery
AU2016358257B2 (en) 2015-11-19 2023-08-17 Universitat Basel Virulence attenuated bacteria for treatment of malignant solid tumors
PT3559022T (pt) 2016-12-20 2021-08-19 Univ Basel Distribuição de proteínas baseada em bactérias com virulência atenuada

Also Published As

Publication number Publication date
CN108884466A (zh) 2018-11-23
BR112018009782A2 (pt) 2018-11-06
IL259050B2 (en) 2024-03-01
CA3005380A1 (en) 2017-05-26
WO2017085235A1 (en) 2017-05-26
EA201890914A1 (ru) 2018-12-28
HRP20201792T1 (hr) 2020-12-25
HK1256138A1 (en) 2019-09-13
US20190194670A1 (en) 2019-06-27
SI3377634T1 (sl) 2021-01-29
SG11201803642WA (en) 2018-06-28
JP2019500027A (ja) 2019-01-10
PT3377634T (pt) 2020-11-16
CY1123654T1 (el) 2022-03-24
ZA201803901B (en) 2019-04-24
AU2016355975B2 (en) 2022-12-08
BR112018009782A8 (pt) 2019-02-26
RS61046B1 (sr) 2020-12-31
EA039922B1 (ru) 2022-03-28
SMT202000620T1 (it) 2021-01-05
AU2016355975A1 (en) 2018-05-10
JP6937752B2 (ja) 2021-09-22
EP3377634A1 (en) 2018-09-26
EP3377634B1 (en) 2020-08-12
ES2830251T3 (es) 2021-06-03
IL259050A (en) 2018-07-31
LT3377634T (lt) 2020-12-28
CN108884466B (zh) 2022-06-03
KR102689434B1 (ko) 2024-07-29
KR20180081798A (ko) 2018-07-17
DK3377634T3 (da) 2020-11-16
IL259050B1 (en) 2023-11-01
US11702663B2 (en) 2023-07-18
HUE051184T2 (hu) 2021-03-01

Similar Documents

Publication Publication Date Title
IL283280B1 (en) Providing bacteria-based proteins
ZA201803901B (en) Bacteria-based protein delivery
GB2521845B (en) Content delivery
GB201502305D0 (en) Protein
GB201502306D0 (en) Protein
GB201415344D0 (en) Protein
HUE050893T2 (hu) Protein
GB201515745D0 (en) Proteins
GB201511787D0 (en) Proteins
HUE047207T2 (hu) Bortezomib alapú adagolórendszer
GB201402533D0 (en) Sensed content delivery
IL248276A0 (en) Carbohydrate binding proteins
GB201513033D0 (en) Proteins
PL3099793T3 (pl) Białko
GB2524838B (en) Content delivery architecture
GB201522610D0 (en) Protein
GB201603775D0 (en) Content delivery
GB201711779D0 (en) Delivery
GB201515337D0 (en) Protein Expression
GB201522636D0 (en) Delivery system
GB201515744D0 (en) Proteins
GB201505292D0 (en) Delivering content
GB201503778D0 (en) Proteins
GB201414371D0 (en) Protein modification